Open Pharma quarterly update: October–December 2023

Caitlin Edgell

We’ve had another great quarter here at Open Pharma, with our successful summit sessions and some useful new resources.

In October, we were pleased to welcome Astellas as our newest Open Pharma Supporter. October also saw the launch of our open access objection handler and our webinar on open access as part of our International Open Access Week 2023 social media campaign.

In November, we hosted our summit sessions. This series of three meetings brought together opinion leaders from pharma and beyond to discuss plain language summaries, open access, and data and metadata.

We look forward to getting out and about at conferences in the next quarter, including the 2024 European Meeting of the International Society for Medical Publication Professionals, where we will be hosting two roundtable sessions on open access and data sharing. We are also excited to host an Open Pharma hybrid meeting to coincide with the conference.

All of us at Open Pharma wish you a peaceful and restful holiday period, and we look forward to seeing you in the new year!

Learn more about what we’ve been up to below or click here.